New cell therapy KITE-197 takes on tough lymphoma
NCT ID NCT06079164
First seen Jan 08, 2026 · Last updated Apr 30, 2026 · Updated 20 times
Summary
This early-stage study tests a new treatment called KITE-197 for people with a type of blood cancer (large B-cell lymphoma) that has come back or not responded to other treatments. The study has two parts: first, to find a safe dose, and second, to see how well that dose works at making the cancer disappear. About 39 participants will receive the therapy and be closely monitored for side effects and response.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RELAPSED/REFRACTORY LARGE B CELL LYMPHOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Cross Cancer Institute
Edmonton, T6G 1Z2, Canada
-
Henry-Joyce Cancer Clinic
Nashville, Tennessee, 37232, United States
-
Jewish General Hospital
Montreal, H3T 1E2, Canada
-
QEII Health Sciences Centre
Halifax, B3H 2Y9, Canada
-
Royal Brisbane and Women's Hospital
South Brisbane, Queensland, 4101, Australia
-
Royal Prince Alfred Hospital
Camperdown, New South Wales, 2050, Australia
-
St. David's South Austin Medical Center
Austin, Texas, 78704, United States
-
Swedish Cancer Institute
Seattle, Washington, 98104, United States
-
Sylvester Comprehensive Cancer Center
Miami, Florida, 33136, United States
-
The Alfred Hospital
Melbourne, Victoria, 3004, Australia
-
University of Chicago Medical Center
Chicago, Illinois, 60637, United States
Conditions
Explore the condition pages connected to this study.